| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-291X(92)91533-V |
| P698 | PubMed publication ID | 1333186 |
| P2093 | author name string | H. Sekiya | |
| T. Nakazawa | |||
| N. Kato | |||
| K. Shimotohno | |||
| M. Hijikata | |||
| Y. Ootsuyama | |||
| S. Ohkoshi | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 119-127 | |
| P577 | publication date | 1992-11-01 | |
| 1992-11-30 | |||
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus | |
| P478 | volume | 189 |
| Q33688319 | A peptide mimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti‐HCV sera |
| Q42984342 | Analysis of the Hypervariable Region of Hepatitis C Virus E2/NS1 Gene in an Infant Infected by Blood Transfusion |
| Q41089053 | Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes |
| Q27473441 | Antigenic structure of the hepatitis C virus envelope 2 protein |
| Q35942829 | Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding |
| Q27469409 | Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs |
| Q28476674 | Cell Culture Replication of a Genotype 1b Hepatitis C Virus Isolate Cloned from a Patient Who Underwent Liver Transplantation |
| Q38234934 | Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies |
| Q43036067 | Characterization of the 5′ noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment |
| Q42978762 | Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. |
| Q42996047 | Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates |
| Q42978218 | Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma |
| Q55383950 | Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2. |
| Q33691856 | Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2. |
| Q27861119 | Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes |
| Q34485144 | Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome |
| Q42990146 | Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). |
| Q40824302 | Detection of non-primate hepaciviruses in UK dogs |
| Q42991400 | Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver |
| Q43048847 | Diversification of hypervariable region 1 of hepatitis C virus after liver transplantation |
| Q27485985 | Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation |
| Q27481026 | Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding |
| Q43037741 | Fraction‐specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia |
| Q27490315 | Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection |
| Q27469536 | Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus |
| Q43032340 | Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2. |
| Q27485921 | Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection |
| Q43037735 | Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients |
| Q59357562 | Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome |
| Q47260983 | Hepatitis C Virus: Viral Quasispecies and Genotypes |
| Q43040543 | Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region |
| Q35105688 | Hepatitis C virus genetic variability: pathogenic and clinical implications |
| Q42988112 | Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus |
| Q39483634 | High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease. |
| Q27486056 | Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus |
| Q35172385 | Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4 |
| Q37859393 | Immunotherapeutic Potential Of Neutralizing Antibodies Targeting Conserved Regions Of The HCV Envelope Glycoprotein E2 |
| Q41626355 | Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy |
| Q27469851 | Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity |
| Q41044112 | Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins |
| Q45752127 | Limited humoral immunity in hepatitis C virus infection |
| Q27469355 | Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus |
| Q21245104 | NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b |
| Q27485952 | Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses |
| Q42985458 | Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism |
| Q27480288 | Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients |
| Q55657826 | Predicting the Effectiveness of Hepatitis C Virus Neutralizing Antibodies by Bioinformatic Analysis of Conserved Epitope Residues Using Public Sequence Data. |
| Q94329268 | Public Health and Hepatitis C |
| Q42980848 | Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma |
| Q36956517 | Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents |
| Q40591268 | Renal manifestations of hepatitis C virus infection |
| Q39406155 | Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function |
| Q34072573 | Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. |
| Q27478447 | Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses |
| Q43041866 | Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak |
| Q41098844 | Sequence variability of hepatitis C virus and its clinical relevance |
| Q34064882 | Structural basis for broad neutralization of hepatitis C virus quasispecies |
| Q35105684 | Structural biology of hepatitis C virus |
| Q41619358 | Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies. |
| Q27490948 | The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule |
| Q35122636 | The hepatitis C virus persistence: how to evade the immune system? |
| Q43035187 | The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1. |
| Q40397337 | Variability of hepatitis C virus |
| Q42013797 | Viral loads and E2/NS1 region sequences of hepatitis C virus in hepatocellular carcinoma and surrounding liver |
| Q71804793 | Virology of hepatitis C virus |
| Q43036337 | Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70. |
| Q27469430 | Wide range of quasispecies diversity during primary hepatitis C virus infection |
| Q33815695 | Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients |
Search more.